Integra LifeSciences to present at 2026 Truist Securities MedTech Conference
Integra LifeSciences Holdings Corporation announced that Bob Davis, executive vice president and president Tissue Reconstruction, will present at the 2026 Truist Securities MedTech Conference on June 16, 2026 at 3:00pm ET. A live webcast will be available on the company's investor relations website.
*this image is generated using AI for illustrative purposes only.
Integra LifeSciences Holdings Corporation announced that Bob Davis, executive vice president and president Tissue Reconstruction, will present at the 2026 Truist Securities MedTech Conference on June 16, 2026 at 3:00pm ET. The presentation will provide insights into the company's operations and strategic direction within the medical technology sector.
A live webcast of the presentation will be accessible on the Integra LifeSciences investor relations website under the Events & Presentations section. This allows investors and stakeholders to listen to the session in real-time.
Integra LifeSciences is a global medical technology company focused on neurosurgery and tissue reconstruction. The company's portfolio includes differentiated technologies used by healthcare professionals for life-saving care.
Conference Details
| Event | Date | Time | Presenter |
|---|---|---|---|
| 2026 Truist Securities MedTech Conference | June 16, 2026 | 3:00pm ET | Bob Davis |
For further information, investors can contact Chris Ward, and media inquiries can be directed to Laurene Isip.
What strategic priorities for the Tissue Reconstruction division is Bob Davis likely to highlight?
How might Integra's product pipeline evolve by mid-2026 to support its growth in neurosurgery?
What impact could current MedTech market trends have on Integra's competitive positioning?
18
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
